Cetera Investment Advisers
HRMY icon

Cetera Investment Advisers’s Harmony Biosciences HRMY Stock Holding History

Cetera Investment Advisers’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Buy
+6,121
New +$193K ﹤0.01% 4411
2026
Q1 		– Sell
-9,196
Closed -$344K – 4874
2025
Q4 		$344K Buy
9,196
+850
+10% +$27.9K ﹤0.01% 3775
2025
Q3 		$230K Sell
8,346
-58
-0.7% -$2K ﹤0.01% 4054
2025
Q2 		$266K Buy
8,404
+748
+10% +$24.1K ﹤0.01% 3497
2025
Q1 		$254K Buy
7,656
+754
+11% +$27K ﹤0.01% 3410
2024
Q4 		$237K Sell
6,902
-46
-0.7% -$1.58K ﹤0.01% 3291
2024
Q3 		$278K Sell
6,948
-536
-7% -$18.8K ﹤0.01% 3130
2024
Q2 		$226K Sell
7,484
-1,523
-17% -$45.8K ﹤0.01% 3284
2024
Q1 		$302K Buy
+9,007
New +$289K ﹤0.01% 3033

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cetera Investment Advisers's HRMY Position: Q2 2026 in Review

Cetera Investment Advisers opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 6,121 shares worth $223K. The stake represents ﹤0.01% of the portfolio and ranks #4411 among its holdings. This is a return to the name: Cetera Investment Advisers previously reported a position in HRMY as recently as Q4 2025.

Cetera Investment Advisers first reported a position in HRMY in Q1 2024 and has held it in 9 quarters since. The position peaked at $344K in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Cetera Investment Advisers held 6,121 shares of Harmony Biosciences worth $223K as of Q2 2026.
  • Harmony Biosciences was a new Cetera Investment Advisers position in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4411 holding.
  • Cetera Investment Advisers first reported a position in Harmony Biosciences in Q1 2024 and has held it in 9 quarters since.
  • Cetera Investment Advisers's Harmony Biosciences position peaked at $344K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.